Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.
In life sciences, enterprise value only emerges when generative AI is treated as a business capability and embedded into existing operating models.
PraxisPro, a data intelligence company rebuilding the fractured state of Life Sciences, has announced the close of its oversubscribed $6 million seed round. AlleyCorp led the funding, with additional ...
Outlining four developments set to change how life-sciences organizations design, deploy, and govern intelligent systems in the year ahead.
The MarketWatch News Department was not involved in the creation of this content. EVANSTON, Ill., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Beghou announces the Beghou Arc Platform, a flexible, connected ...
Anthropic announced Claude for Life Sciences, an AI integration for researchers to advance scientific discovery. Claude for Life Sciences is built around Anthropic's existing AI models and supports ...
A medical device company from Ireland, a biotech startup developing cancer therapeutics from Pennsylvania and a venture studio focused on women’s health from Massachusetts are among eight recipients ...
Oct. 20 (UPI) --Anthropic on Monday announced a new service called Claude of Life Sciences that uses artificial intelligence in efforts to advance scientific discovery. This is the San Francisco-based ...
In the life sciences and healthcare industries, the speed of innovation impacts how soon new products, medications and treatments make it to market—and, in turn, how quickly people are able to benefit ...